Loading resource…

Matteo Sclafani, MD; Marco Spartera, MD, DPhil; Yasmin Esmati, MD; Olivia Baynham-Williams, MSc; Ianna Khan, BSc; Myra Brigoli, BSc; Catherine Krasopoulos, MSc; Julian Ormerod, BM, BCh, PhD; Pok-Tin Tang, BM, BCh; Oliver Rider, BM, BCh, DPhil; Ladislav
The LOSE-AF randomized clinical trial was conducted to assess the impact of weight loss on older adults aged 60 to 85 years with persistent atrial fibrillation. The trial involved approximately 500 participants who were randomized to an 8-month low-calorie diet intervention. The study aimed to determine if weight loss could improve health outcomes without adverse effects on physical performance or AF-related symptoms.
No account needed